MGC Pharma (ASX:MXC)

  • Symbol:ASX:MXC
  • Ticker 2:OTC:MGCLF
  • Sector:Healthcare
  • Industry:Pharmaceutical
  • CEO:Roby Zomer
  • Founded:2005
Categories:

MGC Pharma (ASX:MXC) Stock Price

MGC Pharma (ASX:MXC) Company Overview

MGC Pharmaceuticals (ASX: MXC) is a biotech firm that is currently developing a number of cannabis-based medicinal products such as "CogniCann", which is intended to treat patients suffering from dementia and Alzheimer's.

The company's manufacturing facility in Slovenia recently received one of the European Union's first approvals to extract and develop Phytocannabinoid active pharmaceutical ingredients (API). This will give MGC a considerable competitive advantage as it pursues full vertical integration in the increasingly crowded biopharma market.

MGC Pharmaceuticals was also the first Australian cannabis company to be granted qualification for all of its' Phytomedicines from the European Medicines Agency, allowing it to apply for drug evaluation and registration of CogniCann, CannEpil, and any other medicinal cannabis products currently being developed.

CannEpil is another cannabis-based medicine developed by MGC that is intended to aid the sufferers of epilepsy regulate their symptoms. A growing amount of medical practitioners have already been granted approval to prescribe the drug to Australian patients.

MGC Pharma (ASX:MXC) Financials

More From MGC Pharma...

London Calling – MGC Pharma Progresses Towards LSE Listing and Secures $4.75 Million
MGC Pharma Hits 100 Patients In Australia and Secures New Distribution Partner
MGC Pharma Completes Beta Testing For Nutraceutical Products
MGC Pharmaceuticals Updates the Market on Brain Cancer Trials
King of the Hill – THC Global Receives "Most Significant" Cannabis License in Australia
Sailing Ahead – MGC Pharma Reports Impressive June Quarterly Results
MGC Pharma Signs New Distribution Agreement With German Company
Pushing the Limits – Valens Scales Up Extraction Capacity and Receives TSXV Listing Approval
Distribution Partners Increase Orders by 50% from MGC Pharma
MGC Pharma partners with RMIT to Build Digital Cannabis Database
Load More Results

Investor Presentation

The latest update from the company

Click Here
Stay updated about
this company

Signup to get updates.

Management

Roby Zomer
Co-Founder & Managing Director
Roby Zomer brings 10 years of experience in the BioTech and AgroTech sectors alongside running large scale projects to his role as Managing Director.

Zomer intialy joined MGC Pharmaceuticals as the company’s Executive Director & CTO—bringing his extensive business contacts, scientific and engineering skillset to the role—before being appointed to CEO following the successful implementation of MGC’s pipelines for Pharma in Australia and Slovenia.
Nativ Segev
Founder, Director & Head of Business Strategy
Nativ Segev has over 10 years of experience in implementation, legislation and lobbying in the global medical cannabis industry, combined with over 15 years of experience in various executive roles.

He was previously employed as the CEO of a leading cannabis company with a large patient base, before founding MGC Pharmaceuticals with the goal of raising the quality of—and access to—Medicinal Phytocannabinoid products for patients worldwide.
Brett Mitchell
Executive Chairman
Brett Mitchell is a corporate finance executive with over 20 years of experience in the finance and resources industries. He holds a Bachelor of Economics from the University of Western Australia and is also a member of the Australian Institute of Company Directors (AICD).

Mitchell has also been involved in the founding, financing and management of private and publicly listed resource companies, and holds both executive and non-executive directorship roles.
Dr. Ross Walker
Director & Head of Advisory Board
Dr Ross Walker is an eminent practicing cardiologist with over 35 years’ experience as a clinician.

For the past 20 years, Walker has been focusing on preventative cardiology, and is considered to be one of Australia’s leading preventative health experts.

He is also the author of seven best-selling books, and a health presenter in the Australian Media, as well as having a weekly radio show on Sydney’s 2UE/ 4BC &2CC.